OncoHost announced that Ron Andrews has joined the company as Strategic Consultant to the CEO. In this role, Andrews will support OncoHost’s growth strategy, while also providing strategic leadership in fueling the company's development and expansion initiatives.
With over 35 years in the diagnostics and molecular diagnostics industry, Andrews has successfully led organizations ranging from Fortune 500 divisions to innovative startups. His executive experience spans global industry leaders including Abbott Diagnostics, Roche Molecular Diagnostics, and LifeTechnologies/Thermo Fisher, as well as public CEO roles at Clarient Inc and Oncocyte Inc.
In addition to his position at OncoHost, Andrews currently serves as a trusted advisor to prominent venture capital firms, as well as guiding emerging molecular technology companies through critical product development and fundraising stages. His financial acumen has driven over $600M in successful capital raises and more than $15B in strategic exits over the course of his career.
Throughout his professional life, Andrews has championed the democratization of diagnostic technologies, empowering community oncologists and pathologists with tools for precise, timely patient care. A passionate advocate for leadership development, he has mentored over 15 CEOs and senior executives. Andrews holds a BS in Biology from Wofford College and is actively engaged in various governance roles across public, private, and nonprofit sectors, further demonstrating his commitment to advancing healthcare innovation.
